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Green tea (Camellia sinensis) is one of the most widely consumed beverages in the world. The cancer che-
mopreventive qualities of green tea have been well documented. Epigallocatechin gallate (EGCG) is often
described as the most potently chemopreventive green tea catechin; however, the low bioavailability of
EGCG is a limiting factor for its biological effect. Thus, the aim of this work was to test the chemopreven-
tive potential of green tea extract and EGCG after tannase-mediated hydrolysis. The results showed that
the biotransformed compounds retained most of the beneﬁcial properties of the original compounds, and
some beneﬁcial properties were improved in the biotransformed compounds. Biotransformation of EGCG
decreased its toxicity without affecting its antiproliferative effects. Furthermore, human cells gene
expression proﬁling showed that the biotransformed compounds modulated the expression of several
genes related to carcinogenesis. These results demonstrate the beneﬁts of the biotechnological modiﬁca-
tion of natural food molecules, allowing the improvement of the nutraceutical potential of a beverage as
green tea.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Green tea is one of the most widely consumed beverages in the
world. Epidemiologic research has revealed that individuals who
drink large quantities of green tea are less likely to develop cancer
(Kato et al., 1990; Yu et al., 1995). Recently, a relationship between
the consumption of green tea and a reduced risk of type 2 diabetes
was also reported (Iso, Date, Wakai, Fukui, & Tamakoshi, 2006).
Green tea contains many compounds considered to promote
health, such as polyphenolic ﬂavonoids, of which epigallocatechin
gallate (EGCG) is the major constituent. The cancer chemopreven-
tive function of green tea catechins has been well documented, and
in particular, EGCG has been shown to have anticarcinogenic activ-
ity in vitro (Banerjee, Manna, Saha, & Panda, 2005; Cooper, Morre, &
Morre, 2005; Maeta, Nomuro, Takatsume, Izawa, & Inoue, 2006).
EGCG, often described as the major biologically active component
in green tea, is one of the most potent catechins capable of inhib-
iting cell proliferation and inducing apoptosis in cancer cells
(Shimizu, Adachi, Masuda, Kozawa, & Moriwaki, 2011).
Phenolic compounds also contribute to the chemopreventive
activity of tea through antioxidant activity mediated by their redox
properties, which allows them to act as reducing agents, singlet-
oxygen quenchers and metallic-ion chelators (Atoui, Mansouri,nt, Faculty of Food Engineer
83-862 SP, Brazil. Tel.: +55
).
sevier OA license.Boskou, & Kefalas, 2005). Polyphenols are reducing agents and
are considered the most common antioxidants in our diet, how-
ever, the chemical structure of these compounds may affects their
biological properties such as bioavailability, antioxidant activity
and interactions with speciﬁc cell receptors and enzymes (Scalbert
& Williamson, 2000).
Despite the proven antioxidant capacity of tea polyphenols,
many clinical studies and animal models have shown that these
compounds, and especially their polymers, esters, and glycosides,
are abundant but are not always absorbed upon oral administra-
tion. The functional effect of the compound depends not only on
the amount ingested, but also on its bioavailability (Holst &
Williamson, 2008). Studies have shown that the enzymatic hydro-
lysis of polyphenols results in not only increased absorption, but
also increased antioxidant activity when compared to the original
unmodiﬁed compounds. This is especially true of the conversion of
the most abundant polyphenol of green tea, epigallocatechin gal-
late, into epigallocatechin, which possesses higher antioxidant
activity (Battestin & Macedo, 2007).
Considering the broad variation in the amounts of available
phenolic antioxidants via diet, in combination with reduced bio-
availability, strategies to enrich the diets with phenolic antioxi-
dants needed to be develop with consistent phytochemical
proﬁle for enhanced health beneﬁts (Vattem & Shetty, 2003). As
an alternative, bioprocesses, such as fermentation or enzymatic
hydrolysis of plant sources and their products, can release the phe-
nolic glycosides or other conjugates and consequently, enhance the
functional activity of these antioxidants.
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3.1.1.20), are inducible enzymes produced by fungi, yeast and bac-
teria. Tannases have mostly been characterised by their activity on
complex polyphenolics and are able to hydrolyse the ester bond
(galloyl ester of an alcohol moiety) and the depside bond (galloyl
ester of gallic acid) of substrates such as tannic acid, epicatechin
gallate, epigallocatechin gallate, and chlorogenic acid (Garcia-
Conesa, Ostergaard, Kauppinen, & Williamson, 2001).
In this study, the activity of tannase on the extracts of green tea
was investigated. The aim of this work was to evaluate the chemo-
preventive potential of green tea extract and EGCG after an enzy-
matic reaction, catalysed by the tannase, produced by
Paecilomyces variotii (Battestin & Macedo, 2007).2. Materials and methods
2.1. Materials
Green tea was purchased from local markets (Chá Leão). Epi-
gallocatechin gallate (EGCG, 95%), epigallocatechin (EGC, 98%),
2,20-azobis(2-methylpropionamidine) (97%) (AAPH), 2,2-diphe-
nyl-1-picrylhydrazyl (DPPH), sulforhodamine B sodium salt (SRB),
trichloroacetic acid, T1503 Trizma base, thiazolyl blue tetrazo-
lium bromide, agarose (LMP) and Triton X-100 were purchased
from Sigma–Aldrich. All other chemicals were purchased in the
grade commercially available. Fluorescein was purchased from
ECIBRA, and Trolox (97%) was purchased from ACROS Organics.
Cell culture reagents were purchased from Invitrogen.2.2. Enzyme
Tannase was isolated from P. variotii using a previously pub-
lished procedure (Battestin & Macedo, 2007). A 250-ml conical
ﬂask containing 5 g of wheat bran, 5 g of coffee husk, 10 ml of dis-
tilled water and 10% tannic acid (w/w) (Ajinomoto OmniChem
Division, Wetteren, Belgium) was used for the fermentation pro-
cess. The culture medium (pH 5.7) was sterilised at 120 C for
20 min. After sterilisation, the ﬂasks were inoculated with 2.5 ml
(5.0  107 spores/ml) of the pre-inoculum suspension and incu-
bated at 30 C for 120 h. After fermentation, 80 ml of 20 mM ace-
tate buffer, pH 5.0 was added, and samples were shaken at
200 rpm for 1 h. The solution was ﬁltered and centrifuged at
9650g, for 30 min, at 4 C (Beckman J2-21 centrifuge, Beckman-
Coulter Inc., Fullerton, CA, USA). The supernatant was then treated
with solid ammonium sulphate (80% saturation) and incubated
overnight at 4 C. The precipitate was collected by centrifugation
(9650g for 30 min), resuspended in distilled water and dialysed
against distilled water. The dialysed preparation was freeze-dried
and used as crude tannase.2.3. Sample preparation
2.3.1. LC–MS analysis
Samples were prepared, and the enzymatic reaction, catalysed
by the P. variotii tannase, was characterised by LC–MS analysis as
described by Battestin, Macedo, and Freitas (2008) and Macedo,
Battestin, Ribeiro, and Macedo (2011).2.3.2. Preparation of tea extract for antioxidant and cellular assays
In 125-ml Erlenmeyer ﬂasks, 50 ml of distilled water and
250 mg of each sample of tea were combined. The extraction of
compounds from green tea was performed in a water bath, at
100 C, for 30 min. The samples were ﬁltered on ﬁlter paper, and
the extracts were freeze-dried. The resulting powder, referred toas dried tea extract, was used for antioxidant assays (Cao, Soﬁc,
& Prior, 1996).2.3.3. Polyphenol commercial standards
As an identiﬁed representative polyphenol from green tea, stan-
dard commercial epigallocatechin gallate (EGCG, 95%) was used as
a control. This sample was tested and treated with tannase using
the same procedures as were employed for the tea extract.2.4. Enzymatic biotransformation
The extracts obtained from the green tea and the commercial
control samples were used as substrates for enzymatic hydrolysis
by tannase isolated fromP. variotii (Battestin et al., 2008). The dried
tea extract (5 mg) was dissolved in 1 ml of phosphate buffer (pH
7.4, 75 mM) and incubated with 5 mg of tannase, at 40 C, for
30 min. The hydrolysis process was stopped by placing the reaction
in an ice bath for 15 min. The biotransformed tea was used for the
antioxidant assay after suitable dilution with the same phosphate
buffer (pH 7.4, 75 mM) for ORAC and with a 70% methanol solution
for DPPH. For the cellular assays, the samples were diluted with
DMEM.2.5. ORAC assay
ORAC assays were performed using ﬂuorescein (FL) as the ﬂuo-
rescent probe, as described by Macedo et al. (2011). The automated
ORAC assay was carried out on a NovoStar Microplate reader (BMG
LABTECH, Germany) with ﬂuorescence ﬁlters for an excitation
wavelength of 485 nm and an emission wavelength of 520 nm.
The measurements were made in a COSTAR 96 plate. The reaction
was performed at 37 C, the reaction was started by thermal
decomposition of AAPH in a 75 mM phosphate buffer (pH 7.4)
due to the sensitivity of FL to pH. The measurements were per-
formed in triplicate. ORAC values were deﬁned as the difference
between the area under the FL decay curve and the blank (net
AUC). Regression equations between net AUC and antioxidant con-
centration were calculated for all of the samples. A tannase control
was performed, and the ORAC value obtained was subtracted from
the samples treated with the enzyme. ORAC-FL values were ex-
pressed as lmol of Trolox equivalent/mg of tea extract (Cao &
Ito, 2004).2.6. DPPH assay
The potential antioxidant activity of the tea extract was as-
sessed based on the scavenging activity of the stable 1,1-diphe-
nyl-2-picrylhydrazyl (DPPH) free radical, as described by Macedo
et al. (2011). The measurements were performed in triplicate,
and anti-radical activity was calculated using the linear regression
equation determined by plotting the anti-radical activity of Trolox
solutions of known concentrations. Antiradical activity was ex-
pressed as lmol of Trolox equivalent/mg of tea extract.2.7. Cell culture and maintenance
The human gastric adenocarcinoma cell line PG100, the human
colon adenocarcinoma grade II cell line HT29 and the mouse leuke-
mic monocyte/macrophage cell line RAW264.7 were purchased
from the Rio de Janeiro Cell Bank, RJ, Brazil. The cells were cultured
in DMEM supplemented with 5% fetal bovine serum (Invitrogen).
The cells were maintained at 37 C and 5% CO2–95% humidiﬁed air.
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Ninety-six-well culture dishes were inoculated with RAW264.7
cells at a density of 10  104 cells per well. After incubation at
37 C, in an atmosphere of 5% CO2 and 100% relative humidity
for 24 h, the adherent cells were washed once with PBS (phos-
phate-buffered salin). Cells were then incubated in media contain-
ing various concentrations of unmodiﬁed or biotransformed green
tea extract or EGCG (25–150 lg/ml) to observe the toxic effects of
the extracts on the tested cells. Untreated cellswere used as positive
controls. After incubation for 24 h, the cultureswere assayed for cel-
lular viability using the MTT method (Mosmann, 1983) with modi-
ﬁcations described at Madeira, Macedo, and Macedo (2001). The
plates were centrifuged for 10 min at 500g and 4 C. After removing
the medium, 10 ll of MTT solution and 90 ll of PBS were added to
each well of an ELISA plate, and the plate was incubated at 37 C
for 3 h. The formazan was then dissolved by adding 100 ll of 10%
SDS in 0.01 M HCl to each well, and the samples were incubated
for 18 h. Finally, an ELISA plate reader was used to measure the
absorbances of each well at 540 nm.
2.9. Cell proliferation assay
Ninety-six-well culture dishes were inoculated with two hu-
man cell lines, PG100 and HT29, at a density of 5  103 cells per
well. Following incubation for 24 h, the adherent cells were
washed once with PBS (phosphate-buffered solution). Cells were
then incubated in DMEM containing 50–250 lg/ml of unmodiﬁed
or biotransformed green tea extract or EGCG. Positive and negative
controls were also performed. After incubation at 37 C in an atmo-
sphere of 5% CO2 and 100% relative humidity for 48 h, the cultures
were assayed to detect the effects of the tested compounds on cel-
lular proliferation.
Cellular proliferation was measured using the sulforhodamine B
(SRB) assay, which has been described in detail by Monks et al.,
1991. Brieﬂy, adherent cell cultures were ﬁxed in situ by adding
50 ll of cold 50% (w/vol) trichloroacetic acid (TCA) (ﬁnal concen-
tration, 10% TCA) and incubating the samples for 60 min at 4 C.
The supernatant was then discarded, and the plates were washed
ﬁve times with deionised water and dried. One hundred microli-
tres of SRB solution (0.4% w/vol in 1% acetic acid) was added to
each microtiter well, and the cultures were incubated for 10 min
at room temperature. Unbound SRB was removed by washing the
samples ﬁve times with 1% acetic acid. The plates were then air-
dried.
Bound stain was solubilised with Tris buffer, and the optical
densities were read at a single wavelength of 515 nm using an
automated spectrophotometric plate reader.
2.10. Determination of genotoxicity – comet assay
The comet assay was used to detect DNA damage (strand breaks
and alkali-labile sites) at the individual cell level. PG100 gastric
cells were used for this test. Ninety-six-well culture dishes were
inoculated with PG100 cells at a density of 1  106 cells per ml.
Following incubation for 24 h, the cells were then incubated in
DMEM containing 100 or 250 lg/ml of unmodiﬁed or biotrans-
formed green tea extract or EGCG. After 24 h of incubation, the co-
met assay was performed on the exposed cells. The cell positive
control was the cells non-treated with the tea samples.
To detect DNA damage, the alkaline comet assay was performed
on the cell suspensions using a modiﬁed version of the method de-
scribed by Singh, Mccoy, Tice, and Schneider (1998). Brieﬂy, 20 ll of
the cell suspension was mixed with molten 0.5% low-melting-point
agarose (Promega Co., Madison, WI, USA) and spread on agarose-
precoated microscope slides. The slides were immersed overnightin freshly prepared cold lysing solution (2.5 M NaCl, 100 mM
ethylenediaminetetraacetic acid (EDTA), 10 mM Tris, 2% sodium
salt N-lauryl sarcosine, pH 10, with 1% Triton X-100 and 10% di-
methyl sulphoxide; all from Sigma–Aldrich) at 4 C. After incuba-
tion, the slides were washed in cold PBS (Invitrogen Life
Technologies) for 30 min. Subsequently, the cells were exposed to
alkaline buffer (1 mM EDTA and 300 mM NaOH, pH 13.4) at 4 C,
for 40 min to allow DNA unwinding and expression of alkali-labile
sites. Electrophoresis was then conducted in the same solution at
4 C for 20 min at 25 V and 300 mA.
After electrophoresis, the slides were neutralised (0.4 M Tris, pH
7.5), stained with 40 ll EtBr (20 mg/ml) and analysed with a ﬂuo-
rescence microscope (Eclipse E400; Nikon, Melville, NY, USA),
using the Komet 5.5 image analysis system (Kinetic Imaging, Not-
tingham, UK). One hundred randomly selected cells (50 from each
of two replicate slides) were evaluated from each sample, and the
mean olive Tail moment was determined. Tail moment (TM) is de-
ﬁned as the product of the fraction of the total DNA in the tail and
the mean distance of migration in the tail and is calculated by mul-
tiplying tail intensity/sum comet intensity by the tail’s centre of
gravity peak position. A higher percentage of tail DNA signiﬁes a
higher level of DNA damage.2.11. Cancer-related gene expression analysis
Ninety-six-well culture dishes were inoculated with PG100
cells at a density of 10  108 cells per well. Four replicate wells
were inoculated for each sample tested. After incubation at 37 C,
in an atmosphere of 5% CO2 and 100% relative humidity for 24 h,
cells were incubated in media containing pre-deﬁned concentra-
tions (from 50 to 250 lg/ml) of unmodiﬁed or biotransformed
green tea extract or EGCG. Positive controls (untreated cells) were
also performed. After incubation for 48 h, the cultures were as-
sayed for cancer-related gene expression.
The cells were collected, and total RNA was isolated using an
RNeasy tissue kit (QIAGEN). Single-stranded cDNA was synthes-
ised using a High Capacity cDNA Archive Kit (Applied Biosystems,
Foster City, CA, USA) following the manufacturer’s protocol. The
Human Cancer PathwayFinder™ RT2 Proﬁler™ PCR Array (SABio-
sciences, Frederick, MD, USA) was used to evaluate cancer-related
gene expression. This kit provides expression proﬁles of 84 genes
representative of the six biological pathways involved in transfor-
mation and tumourigenesis. Quantitative PCR was performed using
a 7300 Real-Time PCR System (Applied Biosystems, Foster City, CA,
USA), and threshold cycle numbers were determined using RQ
Study Software (Applied Biosystems). Reactions were performed
in duplicate, and the threshold cycle numbers were averaged.
The 50-ll reaction mixtures contained 25 ll of Platinum SYBR
Green Quantitative PCR SuperMix-UDG (Invitrogen™ Life Technol-
ogies, Alameda, CA, USA) and 100 ng of cDNA. The reactions were
cycled with preliminary UDG treatment for 2 min at 50 C and
denatured for 2 min at 95 C, followed by 45 cycles of denaturation
at 95 C for 15 s, annealing for 15 s, and primer extension at 72 C
for 15 s. This was followed by a melting point analysis of the dou-
ble-stranded amplicons consisting of 40 cycles with a 1 C decre-
ment (15 s each), beginning at 95 C. The data were analysed
using web-based PCR data analysis (SABiosciences) and normalised
against the expression of each tested gene in control cells.2.12. Calculations and statistics
Values are expressed as arithmetic means. The statistical signif-
icance of the differences between the groups was analysed using
the Tukey test. Differences were considered signiﬁcant when
P < 0.05.
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3.1. Antioxidant activity
Various methods have been developed to characterise the total
antioxidant capacity of biological ﬂuids and natural products. One
such method, the semi-automated ORAC protocol developed by
Cao et al. (1996), has been extensively utilised in the ﬁeld of anti-
oxidant activity and oxidative stress.
Table 1 describes the antioxidant capacities of the samples
(EGCG and green tea extract) before and after tannase treatment,
as determined by the ORAC-FL and DPPH methods. For the ORAC
assays, the linearity between the net AUC and the sample concen-
trations was determined for all compounds (Table 1). For each
sample, the solutions with concentrations within the linearity
range resulted in the same ORAC-FL values.
As described previously by Macedo et al., 2011, the results of
the ORAC analyses (Table 1) indicate that the antioxidant capacity
of the tea increased after tannase treatment. The tannase hydroly-
sed the substrates contained in the tea on the same way of it did to
the pure EGCG standard, and the products of hydrolysis apparently
contributed to the observed increase in the tea’s antioxidant capac-
ity. The antioxidant capacity of the green tea sample increased by
55% after enzymatic treatment. Similarly, biotransformation in-
creased the antioxidant activity of the commercial EGCG by 46%.
These results indicate that the tannase from P. variotii was able
to hydrolyse the ester bonds of natural substrates. Epigallocatechin
and gallic acid can be formed by the degalloylation of the gallate
(epigallocatechin gallate) present in the tea extract (Fig. 1). Accord-
ing to Battestin et al. (2008) and Macedo et al. (2011), tannase can
completely hydrolyse the epigallocatechin gallate in green tea to
epigallocatechin and gallic acid by increasing the antioxidant activ-
ity of tea.
Table 1 also describes the antioxidant capacity of the EGCG and
green tea extract before and after tannase treatment, as deter-
mined by the DPPH method. The DPPH assay has been used many
times before to demonstrate the high antioxidant potential of
green tea. Komes, Horzˇic, Belšcˇak, Ganic´, and Vulic´ (2010) used
DPPH, among other methodologies, to relate the elevated antioxi-
dant capacity of green tea samples to their EGCG concentrations.
The results in Table 1 indicate a trend toward increased radical-
scavenging capacity after enzymatic hydrolysis. This trend was
similar to the one observed in ORAC assays, supporting the results
obtained by enzymatic treatment of the extracts.
Catechins (including epicatechins) with three hydroxyl groups
in the B ring are known as gallocatechins, and those esteriﬁed to
gallic acid at the 3-OH group in the C ring are known as catechin
gallates (Fig. 1). With antioxidant activity governed broadly by
the rule that the structures with the most hydroxyl groups exert
the greatest antioxidant activity, the catechin-gallate esters reﬂectTable 1
Trolox equivalents and linearity ranges for the ORAC assay (net AUC vs. concentration) p
control and biotransformed samples by DPPH.
Samples ORAC
Trolox equivalents (lmol/g dry
sample)
Sample concentratio
ml)
Tea extract samples
Green tea 4704 ± 138a 0.2–0.06
Green tea
biotransformed
7356 ± 616b 0.2–0.06
Commercial standard
EGCG 11,735 ± 886a 0.2–0.02
EGCG biotransformed 17,182 ± 514b 0.2–0.01
a,bResults are presented as the mean (n = 3) ± SD, and those with different letters are sigthe contribution of gallic acid (Rice-Evans, Miller, & Paganga,
1996). Potential structure–activity relationships have been sug-
gested by ﬁndings that the o-dihydroxy groups in the B-ring and
the hydroxyl group in the C-ring are associated with the antioxi-
dant properties of the ﬂavonoids (Faria, Oliveira, Gameria,
Santos-Budga, & De Freitas, 2005).
3.2. Cytotoxicity and cell proliferation assay
The effects of EGCG on cellular growth have been extensively
studied using MTT assays. The authors of some studies have inter-
preted the results of MTT assays to indicate that EGCG exerts anti-
proliferative activity (Uesato et al., 2001); however, other authors
have described these effects as a potentially dose-dependent toxic
effect of this compound (Schmidt et al., 2005). In order to distin-
guish between cytotoxic and antiproliferative effects and to
compare the effects of compounds before and after biotransforma-
tion, we used the MTT assay to evaluate cytotoxic effects and the
SRB assay to study anti-proliferative activity.
MTT assays were performed to assess the cytotoxicity of green
tea extract and EGCG before and after biotransformation on the
RAW 264.7 cells (Fig. 2a and b). The data in Fig. 2a reveal a trend
toward a dose-dependent effect, with a small decrease in absor-
bance when higher concentrations of either unmodiﬁed or bio-
transformed green tea extract were used. At each concentration,
no signiﬁcant differences could be observed between the samples
treated with tannase and the untreated samples. In contrast, bio-
transformation of EGCG eliminated the dose-dependent effect, as
the absorbances remained constant for every concentration, with
a small decrease compared to the positive control (Fig. 2b). In gen-
eral, the absorbances of all samples tested varied less than 15%
from those of the positive control. Changes of this magnitude are
not indicative of cytotoxicity, but may instead indicate a decrease
in cellular metabolism.
The results of the SRB assay are shown in Table 2. The rates of
cellular proliferation in treated cultures are normalised to those
of positive control cells. In agreement with previously published
studies (Hwang et al., 2006; Jung et al., 2001; Yang, Liao, Kim,
Yurkow, & Yang, 1998), the green tea extract demonstrated anti-
proliferative activity in HT29 cells; however, this antiproliferative
activity was not observed in PG100 cells. Independent of the par-
ticular response of each cell line, the biotransformation of the
green tea extract resulted in a higher degree of inhibition of cellu-
lar growth at almost every concentration tested in both cell lines.
Unmodiﬁed EGCG demonstrated a strong cytocidal antiprolifer-
ative effect at a range of concentrations in PG100 cells. Interest-
ingly, biotransformation of EGCG inhibited this cytocidal effect
without signiﬁcantly affecting its antiproliferative activity. This
ﬁnding points to potentially interesting avenues for future studies
of cancer chemoprevention.erformed on the control and biotransformed samples and Trolox equivalents of the
DPPH
n range (mg/ Slope Intercept r2 Trolox equivalents (lmol/g dry
sample)
146.16 5.62 0.99 2682 ± 08a
265.35 5.38 0.99 3302 ± 58 b
242.18 7.48 0.96 1551 ± 32a
260.86 7.18 0.97 1869 ± 09 b
niﬁcantly different, with p < 0.05.
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Studies by Morley et al. (2005) and Malhomme de la Roche et al.
(2010) investigated whether ingestion of green tea by healthy hu-
man volunteers afforded any genotoxic protection to their circulat-
ing peripheral leukocytes upon experimental exposure to various
amounts of UVR radiation. Both studies used the comet assay to
determine the genotoxic protection potential of green tea on hu-
man cells and demonstrated that up to 90 min following green
tea ingestion, there was a signiﬁcant decrease (p < 0.05) in DNA
damage (detected by alkaline single cell gel electrophoresis (the
comet assay)) in peripheral leukocytes when they were subse-
quently exposed to 12 min of UVA/VIS irradiation.
In the present work, the comet assay was performed on cells
treated with biotransformed or unmodiﬁed green tea extracts.
These experiments demonstrated signiﬁcantly reduced Tail Mo-
ment (TM) values when compared to positive control cells, demon-
strating that green tea extract provided protection against DNA
damage (Table 3). The TM data obtained for these samples were
statistically smaller than the cell control. This is a clear indication
of DNA damage protection capacity of the tested samples. The TM
values appeared to be negatively correlated with the concentration
of green tea extract and were slightly higher in samples treated
with biotransformed extract than in samples treated with unmod-
iﬁed extract; however, TM values of all treated cell cultures were
statistically similar and signiﬁcantly smaller than those of control
cell cultures.
Analysis of the TM values of samples treated with EGCG (Table
3) demonstrated that except for one condition (treatment with
250 lg/ml unmodiﬁed EGCG), all samples were statistically similar
to the positive control sample. These results show that the tested
concentrations of EGCG were not genotoxic, meaning that they
did not induce any signiﬁcant DNA damage in the tested cells. Bio-
transformation of EGCG with tannase did not alter these results.
3.4. Cancer-related gene expression analysis
In summary, our data show that unmodiﬁed and biotrans-
formed green tea extracts and EGCG were neither cytotoxic nor
genotoxic. Furthermore, we observed that the antioxidant and
anti-proliferative capacities of these compounds were signiﬁcantly
increased by enzymatic intervention. Due to the potential cancer
chemopreventive mechanisms of green tea and EGCG include pre-
vention of DNA damage (Malhomme de la Roche et al., 2010; Mor-
ley et al., 2005), inhibition of inﬂammatory processes, decreased
angiogenesis, and antiproliferative/pro apoptotic effects (Shimizu
et al., 2011; Yang &Wang, 2011), we used the Human Cancer Path-
way Finder Array to evaluate the effects of unmodiﬁed and bio-
transformed green tea extract and EGCG on the expression
proﬁles of 84 genes representative of the six biological pathways
involved in transformation and tumorigenesis. Treatment with
either unmodiﬁed or biotransformed green tea extract signiﬁcantly
changed the expression of 14% of the tested genes (12/84), whereas
treatment with either unmodiﬁed or biotransformed EGCG altered
the pattern of expression of 17% (14/84) of the genes. The statisti-
cally signiﬁcant and biologically relevant results are shown in Ta-
ble 4. The gene expression values presented were obtained by
normalising expression levels to those observed in the control
cells.
In relation to apoptosis and cell cycle control, our data showed
that APAF1 (apoptotic peptidase activating factor 1), CASP8 (cas-
pase 8, apoptosis-related cysteine peptidase), CDKN1A (cyclin-
dependent kinase inhibitor 1A), and FAS (TNF receptor superfamily
member 6) were up regulated by biotransformed green tea extract,
unmodiﬁed EGCG and biotransformed EGCG. We also observed a
down regulation of CDK2 and 4 (Cyclin-dependent kinase 2 and4), bcl2 (B-cell CLL/lymphoma 2), bcl2L1 (BCL2-like-1), E2F1 (E2F
transcription factor 1), and c-myc (V-myc myelocytomatosis viral
oncogene homologue) (Table 4).
APAF1, CASP8 and CDKN1 are closely related to the caspase en-
zyme family. Some of these genes encode members of the caspase
family of proteases, whereas others encode proteins responsible
for caspase activation. In either case, these proteins contribute to
the initiation of the caspase cascade that commits the cell to apop-
tosis (Gramantieri et al., 2005; Jones et al., 2011; Yang, Zhang, Pit-
telkow, Ramoni, & Tsao, 2006). The protein encoded by the FAS
gene is a member of the TNF-receptor superfamily. This superfam-
ily includes FAS, CD40, CD27, and RANK. FAS contains a death do-
main, and the interaction of this receptor with its ligand allows the
formation of a death-inducing signalling complex that includes
Fas-associated death domain protein (FADD), caspase 8, and cas-
pase 10. The autoproteolytic processing of the caspases in this
complex triggers a downstream caspase cascade and leads to apop-
tosis (Idriss & Naismith, 2000). In addition, EGCG has been shown
to cause G0/G1 cell cycle arrest and apoptosis of human epider-
moid carcinoma cells (Ahmad, Feyes, Nieminen, Agarwal, &
Mukhtar, 1997; Ahmad, Gupta, & Mukhtar, 2000). Furthermore,
EGCG treatment of human epidermoid carcinoma cells resulted
in induction of cyclin kinase inhibitors such as CDKN1, which
through downregulation of cyclins D1 and D2 and cyclin-depen-
dent kinases (cdk2, cdk4, and cdk6) causes G0/G1 cell cycle arrest,
ultimately culminating in apoptotic cell death (Ahmad et al., 2000).
In agreement with these data, we demonstrate that all tested com-
pounds induced up regulation of CDKN1A and down regulation of
cdk2 and cdk4.
Analysis of genes encoding members of the BCL-2 family
showed that, although treatment with unmodiﬁed EGCG resulted
in increased expression of the BCL2 (B-cell CLL/lymphoma 2) gene,
treatment with biotransformed EGCG or biotransformed green tea
extract suppressed the expression of this gene. In contrast, the only
signiﬁcant effect on the expression of the BCL2L1 (BCL2-like 1)
gene was the suppression of its expression by the biotransformed
green tea extract. These results showed the superiority of the bio-
transformed samples in down-regulating the expression of these
genes, reducing the generation of BCL-2 proteins, which function
in inhibiting apoptosis.
Leone et al. (2003) showed that green tea catechins are very po-
tent inhibitors of the antiapoptotic Bcl-2 family proteins Bcl-xL and
Bcl-2, suggesting a strong link between the anticancer activities of
these tea polyphenols and their inhibition of a crucial antiapoptotic
pathway. As this pathway has been implicated in the development
of many human malignancies, the reduction of the expression of
these genes is considered a pro-apoptotic function (Yang & Wang,
2011).
In addition, EGCG has been shown to induce apoptosis in S180
cells by altering the G2/M phase of the cell cycle through down-
regulation of the oncogenes c-myc and bcl-2 (Manna, Banerjee,
Mukherjee, Das, & Panda, 2006). Subsequently, Thyagarajan, Zhu,
and Sliva (2007) showed that EGCG suppressed the expression of
the oncogene c-myc in breast cancer cells. Our ﬁndings demon-
strate that all tested compounds signiﬁcantly down regulated the
expression of c-myc.
A key regulator of the G1/S phase transition in the cell cycle is
the retinoblastoma (pRb) tumour suppressor protein (Nevins,
Leone, DeGregori, & Jakoi, 1997). Members of the retinoblastoma
family suppress cell growth, at least in part, by inhibiting E2F-
dependent transcription of genes whose products are required
for DNA synthesis and/or cell cycle progression (Nevins et al.,
1997; Parreño, Garriga, Limón, Albrecht, & Graña, 2001). It has
been shown that the anti proliferative and apoptotic effects of
EGCG may be attributed to the down regulation of pRB and E2F1
proteins, which leads to the inhibition of cell cycle progression,
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Fig. 1. Degalloylation of EGCG by the tannase from Paeciloyces variotii.
Fig. 2. Cytotoxicity by MTT assay in RAW 246.7 cells for various concentrations of the (a) Green tea extract and (b) EGCG, before and after tannase biotransformation.
Table 2
Proliferation modulation results in (%) of the cell positive control growth for each cell type, PG 100 and HT 29.
Samples PG 100 HT 29
Samples concentration (lg/ml)
250 200 150 100 50 250 200 150 100 50
Green tea 100% 100% 97% 109% 99% 66% 47% 63% 64% 93%
Green tea –biotransformed 69% 68% 85% 73% 77% 50% 60% 46% 58% 58%
EGCG 45% 50% 48% 53% 29% 26% 29% 39% 85% 90%
EGCG – biotransformed 77% 86% 86% 79% 72% 39% 53% 58% 54% 64%
Table 3
Effect of Green tea and EGCG intervention on DNA damage levels in gastric cells PG 100 before and after extract’s biotransformation.
Samples DNA damage in PG 100 cells (TM ± SD)
Cell positive control 100 lg/ml 250 lg/ml
Green tea (without tannase) 2.66 ± 0.20 0.85 ± 0.03* 1.07 ± 0.07*
Green tea biotransformed 1.08 ± 0.24* 1.29 ± 0.12*
Epigallocatechin gallate (without tannase) 1.86 ± 0.03 2.97 ± 0.04*
Epigallocatechin gallate biotransformed 2.54 ± 0.17 2.58 ± 0.14
The values represent the mean ± standard deviation for TM of 100 cells in arbitrary units.
* p 6 0.05, compared to the control group.
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(Ahmed, John, Vijayasarathy, Robin, & Raza, 2002). Although we
did not detect down regulation of pRb expression, our data show
a signiﬁcant decrease in E2F1 expression under all tested condi-
tions, suggesting that the inhibition of proliferation we observed
could be partially related to this pathway.
In some cases, the modulation of the expression of genes of
interest caused by unmodiﬁed EGCG was more pronounced thanthat achieved by the biotransformed compound; however, cell
culture assays often ignore the bioavailability of the compounds
in vivo. The literature shows that the systemic bioavailability of
EGCG is a limiting factor for its effectiveness in cancer chemopre-
vention in internal organs (Yang & Wang, 2011). Orally ingested
EGCG has limited systemic bioavailability, with most of it passing
through the colon; and the absorbed EGCG is excreted mostly
through the bile into the intestine (Yang & Wang, 2011). Studies
Table 4
Fold regulation gene expression.
Gene
symbol
Green tea
biotransformed
EGCG EGCG
biotransformed
APAF1 1.41 ± 0.57 2.03 ± 0.87* 1.42 ± 0.39
BCL2 2.70 ± 0.29* 1.56 ± 0.92 1.05 ± 0.65
BCL2L1 2.01 ± 0.79* 1.07 ± 0.18 1.41 ± 0.41
CASP8 1.46 ± 0.44 3.25 ± 0.81* 1.38 ± 0.75
CDKN1A 2.28 ± 0.51* 4.40 ± 0.37** 2.12 ± 0.72*
CDK2 1.96 ± 0.10* 1.87 ± 0.07* 1.99 ± 0.73*
CDK4 1.41 ± 0.18 1.48 ± 0.74 1.45 ± 0.18
E2F1 3.80 ± 0.26* 3.66 ± 0.39* 3.02 ± 0.23*
FAS 1.56 ± 0.32 4.53 ± 0.57** 2.19 ± 0.81*
c-MYC 2.07 ± 0.82* 3.44 ± 0.73* 2.04 ± 0.32*
* p < 0.05 when compared to untreated cells.
** p < 0.01 when compared to untreated cells.
364 J.A. Macedo et al. / Food Chemistry 133 (2012) 358–365have shown that the serum levels of EGCG, EGC, ECG, and EC in
rats 8 h after oral administration of green tea were 0.061, 0.440,
0.018 and 2.6 lM, respectively, demonstrating that the hydroly-
sed forms of EGCG are more efﬁciently absorbed and present at
higher concentrations in the serum (Lubet et al., 2007). Based
on these ﬁndings, although biotransformed EGCG causes less
up-regulation of apoptosis-related genes in vitro than unmodiﬁed
EGCG, the biotransformed compound may be more effective
in vivo.
4. Conclusion
Here, we have shown that the biotransformation of green tea
extract and EGCG did not alter the beneﬁcial properties of the ori-
ginal compounds (low genotoxicity, antiproliferative activity, and
up-regulation of pro-apoptotic genes) and improved their
bioavailability.
The biotransformation of both green tea extract and EGCG sig-
niﬁcantly increased their antioxidant potential, as shown by the
ORAC and DPPH assays. ORAC assays demonstrated that the anti-
oxidant capacity of green tea extract increased by 55% after enzy-
matic treatment, and that of EGCG increased by 46%.
MTT and SRB assays demonstrated that biotransformation did
not render the compounds cytotoxic; instead, biotransformation
reduced the toxicity of the EGCG sample without altering its anti-
proliferative effects on the HT29 and PG100 cell lines. Furthermore,
biotransformation increased the anti proliferative capacity of the
green tea extract.
In relation to apoptosis and cell cycle control, our data showed
that either native and biotransformed green tea and/or EGCG up
regulated the expression of APAF1, CASP8, CDKN1A and FAS; on
the other hand we observed a down regulation of CDK2 and 4,
bcl2, bcl2L1, E2F1, and c-myc.
Importantly, this study has demonstrated the usefulness of the
nutrigenomics perspective and tools in evaluating the beneﬁts of
biotechnological modiﬁcations of natural food molecules. Using
this perspective, we have identiﬁed methods to improve the nutra-
ceutical potential of one of the most widely consumed beverages –
green tea.
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